Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activation of the PI3K-AKT pathway in human malignant mesothelioma cells.

Suzuki Y, Murakami H, Kawaguchi K, Tanigushi T, Fujii M, Shinjo K, Kondo Y, Osada H, Shimokata K, Horio Y, Hasegawa Y, Hida T, Sekido Y. Activation of the PI3K-AKT pathway in human malignant mesothelioma cells. Mol Med Rep. 2009 Mar-Apr; 2(2):181-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.